SC
Basic Science (Poster)
Friday, May 29, 2015: 12:00 PM-2:00 PM
Griffin Hall
RGC-32, FasL, and SIRT1 As Potential Biomarkers of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis
Adam M Kruszewski, B.S., University of Maryland School of Medicine;
Cosmin A Tegla, M.D., University of Maryland School of Medicine;
Cornelia Cudrici, M.D., University of Maryland School of Medicine;
Vingh Nguyen, D.D.S., University of Maryland School of Medicine;
Gautam K Rao, B.S., University of Maryland School of Medicine;
Walter Royal III, M.D., University of Maryland School of Medicine;
Christopher T Bever Jr., M.D., M.B.A., Veterans Administration Multiple Sclerosis Center of Excellence;
Violeta Rus, M.D., Ph.D., University of Maryland School of Medicine;
Horea Rus, MD, PhD, University of Maryland School of Medicine
Gait Termination in Individuals with Multiple Sclerosis
Kathleen L Roeing, BS, University of Illinois at Urbana-Champaign;
Douglas A Wajda, MS, University of Illinois at Urbana-Champaign;
Robert W Motl, PhD, University of Illinois at Urbana-Champaign;
Jacob J Sosnoff, PhD, University of Illinois at Urbana-Champaign
Rocky Mountain Multiple Sclerosis Center (RMMSC) Biorepository for the Study of Neuroimmunological Disorder
Courtney Knapp, BA, University of Colorado;
Enrique Alvarez, MD, University of Colorado Anschutz Medical Campus;
Teri Schreiner, MD MPH, University of Colorado;
Danielle Harlow, PhD, University of Colorado;
Augusto A Miravalle, M.D., University of Colorado;
John Corboy, MD, University of Colorado
